Evaluating Technology and Innovation in Biopharmaceutical Manufacturing

March 11th 2025

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Advances in automation technologies and bioprocessing equipment are driving fuller adoption of automation in biomanufacturing.

September 27th 2024

Advantages of Single-Use Chromatography Systems for Downstream Processing

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Young researcher working with chemical samples in laboratory with HPLC system and chromatography equipment | Image Credit: © BGStock72 – Stock.Adobe.com

Cynthia A. Challener

March 8th 2025

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

The benefits include reduced contamination risks, simplified validation processes, and streamlined operations.

Felicity Thomas

May 25th 2023

EMA Approves TAKHZYRO for Additional Subcutaneous Administration Option to Treat Hereditary Angioedema

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Advancing Biotherapy Production with Continuous Manufacturing

Takeda’s TAKHZYRO (lanadelumab) is now approved in Europe as a subcutaneous injection treatment for hereditary angioedema in patients 12 years old and above and in adults.

Vaccine Production Facility. Medication Manufacturing Process. Glass Vials with Orange Caps on Conveyor Belt. Medical Ampoule Production Line at Modern Pharmaceutical Factory. | Image Credit: © IM Imagery – © IM Imagery– Stock.Adobe.com

Progressing Toward Full Automation in Biomanufacturing

RNA modalities will especially benefit from fuller adoption of continuous manufacturing platforms.

Related Content

March 11th 2025

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Advances in automation technologies and bioprocessing equipment are driving fuller adoption of automation in biomanufacturing.

September 27th 2024

Advantages of Single-Use Chromatography Systems for Downstream Processing

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Cynthia A. Challener

March 8th 2025

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

The benefits include reduced contamination risks, simplified validation processes, and streamlined operations.

Felicity Thomas

May 25th 2023

EMA Approves TAKHZYRO for Additional Subcutaneous Administration Option to Treat Hereditary Angioedema

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Advancing Biotherapy Production with Continuous Manufacturing

Takeda’s TAKHZYRO (lanadelumab) is now approved in Europe as a subcutaneous injection treatment for hereditary angioedema in patients 12 years old and above and in adults.